About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Straberi Microneedling For Atrophic Acne | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04740268

Straberi Microneedling For Atrophic Acne

This pilot study will expand knowledge and application needling using the Straberi microneedling device for the improvement of Atrophic Acne Scarring

Lead sponsor: Universal Skincare Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Universal Skincare Institute

Collaborators

Lavish Beauty

This pilot study will expand the knowledge and application of needling using the Straberi microneedling device and its safety and benefits for improving the appearance of atrophic acne scarring. The pilot aims to objectively measure skin quality using the Derma Scan, photographs, and provide objective data showing improvement by way of the Goodman and Barons quantitative scar scale.

Age

21 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Derma Scan showing aging including skin texture, wrinkles, brown spots, and pores.
•Patients willing to sign informed consent.
•Patients willing to be photographed and video documented
•Patients willing to consent to 3 months of treatment

Exclusion Criteria

•History of eczema in the treatment area; psoriasis and any other chronic skin conditions
•History of actinic (solar) keratosis in the treatment area;
•History of hemophilia
•History of diabetes
•The presence of raised moles, warts on the targeted area.
•Collagen vascular diseases or cardiac abnormalities
•Blood clotting problems
•Active bacterial or fungal infection
•Facial melanosis
•Malignant tumors
•Immunosuppression
•Use of blood thinners or prednisone
•Corticosteroids within two weeks of the procedure
•Chronic liver disease
•Porphyria or other skin diseases.
•Patient not willing to sign informed consent.
•TCA peels in the last 5 weeks
•Subject currently has moderate to severe acne on the face.
•Microneedling within the last 6 months
•Subject has an active infection.
•Subject has a history of a bleeding disorder
•Subject has a history of keloidal tendency
•Subject has received ablative or non-ablative laser treatments in the previous 6 months.
•Subject has taken Accutane within the previous 3 months.

Related studies

Evaluation of the Efficacy and Safety of Microneedling Combined With Botulinum Toxin-A Versus Meso-Botox Injection in the Treatment of Atrophic Acne Scars: A Split-face Comparative Study

NCT06544993 · Atrophic Acne Scar

Not Yet RecruitingNA

Subcision With CO₂ Laser or PRP vs Subcision Alone in Atrophic Acne Scars

NCT07199608 · Atrophic Acne Scar

Autologous Plasma Gel Injection Versus Polydioxanone Cog Threads Insertion for the Treatment of Atrophic Post-acne Scars: a Split-face

NCT06580691 · Acne Vulgaris, Atrophic Acne Scar

Combined Procedures in the Treatment of Severe Acne Scars

NCT06227481 · Atrophic Acne Scar

COMPLETEDPhase 4

Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars

NCT02735421 · Acne Vulgaris, Atrophic Acne Scars

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 6, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment25

Start dateDec 2022

Last updatedDec 6, 2023

Condition

Atrophic Acne Scar

Locations shown

Lavish Beauty

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 6, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions